Jext (Epinephrine Bitartrate)

Epinephrine stimulates alpha and beta adrenergic receptors throughout the body. Alpha‑1 activation causes blood‑vessel constriction, raising blood pressure and reducing swelling, while beta‑2 activation relaxes bronchial smooth muscle, improving breathing. Beta‑1 effects increase heart rate and contractility, supporting cardiac output during shock.

The dose of Jext is determined by a qualified healthcare professional based on the patient’s age, weight, and severity of the reaction, following established emergency‑treatment guidelines. Prescribers select the appropriate volume and concentration to achieve rapid therapeutic effect.

The pregnancy safety category for epinephrine is not definitively established. It should be used in pregnant or breastfeeding women only when the potential benefit outweighs any possible risk to the mother or infant, and under close medical supervision.

To order Jext, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and necessary import documentation.

Jext is a standard epinephrine solution for intramuscular injection, similar in active ingredient to auto‑injector devices such as EpiPen. Unlike pre‑filled auto‑injectors, Jext requires manual drawing and administration, offering flexibility in dosing volume but demanding proper technique and training.

Jext must be stored at 2‑8 °C (refrigerated), protected from light, and must not be frozen or shaken. Keep the vial in its original packaging until use, and discard any solution that appears discolored or contains particles.

Jext is administered by intramuscular injection, preferably into the anterolateral thigh (vastus lateralis). The injection should be given promptly at the first sign of anaphylaxis, using aseptic technique and a suitable needle size to ensure deep muscle delivery.

Serious risks include cardiac arrhythmias, severe hypertension, myocardial ischemia, pulmonary edema, and tissue necrosis at the injection site. Immediate medical monitoring is essential after administration to detect and manage these potentially life‑threatening events.

Jext should be avoided in individuals with known hypersensitivity to epinephrine or any excipients in the formulation. Caution is also advised for patients with certain cardiac conditions, uncontrolled hyperthyroidism, or those taking non‑selective beta‑blockers, where alternative management may be required.